LNSR — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-05-08

• Our revenue decreased from $14.2 million for the three months ended March 31, 2025 to $13.4 million for the three months ended March 31, 2026, representing a decrease of 5%, primarily due to decreased system sales. Our net income was $36.3 million for the three months ended March 31, 2026 compared t…

• On March 23, 2025, we entered into an Agreement and Plan of Merger, or the Merger Agreement, with Alcon Research, LLC, or Alcon, and VMI Option Merger Sub, Inc., or Merger Sub, which provided that, subject to the terms and conditions set forth in the Merger Agreement, Merger Sub would merge with and…

• On May 21, 2025, we and Alcon each received a request for additional information and documentary material from the Federal Trade Commission, or the FTC, in connection with the FTC’s review of the Merger. Following its investigation, the FTC indicated its intention to seek to enjoin the Merger. On Ma…

• During the three months ended March 31, 2026, acquisition-related costs were reduced by $4.4 million associated with previously recognized acquisition-related costs eliminated in conjunction with the terminated Merger Agreement as compared to $4.2 million of acquisition-related costs incurred during…

• Our selling, general and administrative expenses consist primarily of acquisition-related costs, personnel costs, such as salaries and wages, including stock-based compensation and benefits, professional fees, marketing, insurance, travel and other expenses. We are continuing to grow our sales effor…

Text removed vs the prior filing · source: 10-Q · 2025-11-06

• Our revenue increased from $13.5 million for the three months ended September 30, 2024 to $14.3 million for the three months ended September 30, 2025, representing an increase of 6%, primarily due to increased procedure volume. Our net loss was $3.7 million and $1.5 million for the three months ende…

• the nine months ended September 30, 2025 and 2024, respectively. Our installed base of Systems is approximately 425 as of September 30, 2025.

• On March 23, 2025, we entered into an Agreement and Plan of Merger (the “Merger Agreement”), with Alcon Research, LLC (“Alcon”) and VMI Option Merger Sub, Inc. (“Merger Sub”). The Merger Agreement provides that, subject to the terms and conditions set forth in the Merger Agreement, Merger Sub will m…

• On May 21, 2025, the Company and Alcon each received a request for additional information and documentary material, or a Second Request, from the Federal Trade Commission, or the FTC, in connection with the FTC’s review of the Merger. The effect of the Second Request is to extend the waiting period …

• We received $10.0 million as a cash deposit towards the aggregate consideration, which is classified as a current liability on the condensed balance sheet at September 30, 2025. The deposit will be held in accordance with the terms of the Merger Agreement. In connection with a termination of the Mer…

Text added vs the prior filing · source: 10-Q · 2026-05-08

• The announcement of the termination of the Merger Agreement could negatively impact our business, financial condition, results of operations or our stock price.

• Our announcement of having entered into the Agreement and Plan of Merger, dated as of March 23, 2025, by and among the Company, Alcon Research, LLC, a Delaware limited liability company (“Alcon”), and VMI Option Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Alcon (“Merger…

• certain costs related to the Merger Agreement and the transactions contemplated thereunder (collectively, the “Merger”), including the fees and/or expenses of our legal, accounting and financial advisors that must be paid despite the Merger not being completed;

• we could be subject to further litigation related to the Merger, including the failure to complete the Merger.

• We are not able to predict how long these risks will remain relevant following the termination of the Merger Agreement or the ultimate impact of the termination of the Merger Agreement on our business, financial condition and results of operations, including our ability to return to the growth traje…

Text removed vs the prior filing · source: 10-Q · 2025-11-06

• The conditions under the Merger Agreement to our and Alcon’s consummation of the Merger may not be satisfied at all or in the anticipated timeframe.

• On March 23, 2025, we entered into the Merger Agreement with Alcon and Merger Sub, pursuant to which Merger Sub will be merged with and into the Company, with the Company surviving the Merger as a wholly-owned subsidiary of Alcon.

• Consummation of the Merger is subject to the receipt of certain regulatory approvals; the expiration or termination of any applicable waiting period (and extensions thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976; obtaining all waivers and approvals under certain other specif…

• On May 21, 2025, the Company and Alcon each received a Second Request from the FTC, in connection with the FTC’s review of the Merger. The effect of the Second Request is to extend the waiting period imposed by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, or the HSR Act, unt…

• The Company intends to pursue all required approvals in accordance with the Merger Agreement. However, no assurance can be given that the required approvals will be obtained and, even if all such approvals are obtained, no assurance can be given to the terms, conditions and timing of the approvals o…